ADCT — ADC Therapeutics SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	10-K	10-K	10-K	10-K
Standards:	IFRS	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-230	-157	-240	-158	-143
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	46.5	65.9	37.2	27.3	23.8
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-26.4	-46.6	45.9	5.34	-23.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-233	-138	-119	-124	-141
Capital Expenditures	-6.38	-0.687	-3.22	-0.867	-0.264
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.297	—	—	—	0.659
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-6.67	-0.687	-3.22	-0.867	0.395
Financing Cash Flow Items	—	-1.31	—	-1.16	-1.51
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	267	-0.897	73.9	97.1	151
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	27.3	-140	-47.8	-27.7	10.5